These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 35957103)

  • 1. Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy.
    Al Bostami RD; Abuwatfa WH; Husseini GA
    Nanomaterials (Basel); 2022 Aug; 12(15):. PubMed ID: 35957103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle drug delivery systems for synergistic delivery of tumor therapy.
    Chen D; Liu X; Lu X; Tian J
    Front Pharmacol; 2023; 14():1111991. PubMed ID: 36874010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
    Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
    Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy.
    Fumoto S; Nishida K
    Chem Pharm Bull (Tokyo); 2020; 68(7):603-612. PubMed ID: 32611997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers.
    Yaghmur A; Østergaard J; Mu H
    Adv Drug Deliv Rev; 2023 Dec; 203():115136. PubMed ID: 37944644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Nanoparticle-Mediated Co-Delivery System: A Promising Strategy in Medical and Agricultural Field.
    Li M; Sun X; Yin M; Shen J; Yan S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects.
    Li Y; Thambi T; Lee DS
    Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 28941203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug and gene co-delivery systems for cancer treatment.
    Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
    Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
    Babu A; Munshi A; Ramesh R
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1391-1401. PubMed ID: 28523942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micelles as potential drug delivery systems for colorectal cancer treatment.
    Fatfat Z; Fatfat M; Gali-Muhtasib H
    World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
    Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
    Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems.
    Liu H; Zhu X; Wei Y; Song C; Wang Y
    Biomed Pharmacother; 2023 Jan; 157():114065. PubMed ID: 36481408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in siRNA Delivery Systems for Prostate Cancer Therapy.
    Aghamiri S; Raee P; Shahmohamadnejad S; Shabani S; Ghorbani J; Sameni M; Ebrahimi MT
    Curr Pharm Biotechnol; 2022; 23(4):579-593. PubMed ID: 34132181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaCO
    Yang X; Sun Y; Zhang H; Liu F; Chen Q; Shen Q; Kong Z; Wei Q; Shen JW; Guo Y
    Nanoscale; 2024 Apr; 16(14):6876-6899. PubMed ID: 38506154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
    Li J; Wang Y; Zhu Y; Oupický D
    J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.